US FDA Approves Sun Pharma’s Generic Medication for selling.
Sun Pharmaceutical Industries announced that its subsidiary has been granted approval by the US Food and Drug Administration (FDA) to market a generic drug for the treatment of multiple myeloma.
This marks an important milestone for the company and its efforts to bring affordable and accessible treatments to patients in need.